ecancer

Small cell lung cancer: Q & A

Prof Gordon McVie, Prof Caroline Dive, Dr Fiona Blackhall and Dr Marianne Nicolson

5 Oct 2016

Omics, early detection and novel therapies: Epigenetic studies

Dr Adele Murrell - University of Bath, Bath, UK

5 Oct 2016

Small cell lung cancer: New therapies

Dr Fiona Blackhall - The Christie NHS Foundation Trust, Manchester, UK

5 Oct 2016

Small cell lung cancer: Current standards of care

Dr Marianne Nicolson - Aberdeen Royal Infirmary, Aberdeen, UK

5 Oct 2016

We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK

5 Oct 2016

Maintenance in NSCLC: Arguments against

Dr Benjamin Besse - Institut Gustave Roussy, Paris, France

5 Oct 2016

Maintenance in NSCLC: Arguments for

Dr Jaishree Bhosle - The Royal Marsden NHS Foundation Trust, London, UK

5 Oct 2016

Maintenance in NSCLC: Q & A

Dr Besse and Dr Bhosle

5 Oct 2016

Using PDL1 and other biomarkers in patient selection for immunology: Q & A

Dr O'Brien and Prof McVie

5 Oct 2016

We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Prof Gordon McVie - King's College London, London, UK

5 Oct 2016

Imaging and novel PET tracers: Q & A

Dr Giulia Veronesi and Prof Tony Ng

5 Oct 2016

Current standards of care in advanced NSCLC

Dr Frances Shepherd - The Princess Margaret Cancer Centre, Toronto, Canada

5 Oct 2016

More from ecancer